Drawing for TXCELLS

USPTO serial 79400530

TXCELLS

Reviewed by CopyMark Law Group

Reg. 7963033Status 700Registered
Filing date
Status date
Registration date
Sep 30, 2025
Examiner
LE, KIEU-NHI NGOC
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TXCELLS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel Lano

Daniel Lano IpHorgan Ltd.195 Arlington Heights RoadSuite 125Buffalo Grove, IL 60089

Goods and services

ClassDescriptionStatusFirst use
001Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; cells for scientific, laboratory or medical research, namely, skeletal myocytes; cells for scientific, laboratory or medical research, namely, cortical neurons; biological tissue for research and scientific purposes; cultures of cell media for cultivating human or animal cells, other than for medical or veterinary use; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells, namely, substances for microorganism cultures, other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology, other than for medical use; cell growth media for growing cells, tissue culture media for cultivating human or animal cells, proteins in the nature of cytokines, biochemicals in the nature of monoclonal antibodies, and reagents for medical research useACTIVE—
005Cells for medical use, namely, genetically or otherwise modified cells; cells for medical use, namely, cells which are propagated, cultivated and expanded in bioreactors; cells for medical use, namely, cells for the purpose of tissue regeneration; living cells for medical use; cells for medical use; diagnostic preparations for medical or veterinary purposes; biological preparations for use in cell cultures for medical purposes, namely, for drug screening; biological preparations for use in cell cultures for medical purposes, namely, for genetic testing and screening; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media, tissue culture media for cultivating human or animal cells, proteins in the nature of cytokines, biochemicals in the nature of monoclonal antibodies, and reagents for medical or diagnostic use; tissue culture media for cultivating human or animal cells; nutritional supplements, specifically for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, all for medical purposes; cell separation reagents for medical purposes; dietary supplements; protein supplements; nutrition supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 25, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 25, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 25, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 25, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 23, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 8, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 7, 2026FIMPFINAL DISPOSITION PROCESSED—
Jan 8, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 8, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 30, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 24, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 24, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 30, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 30, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 12, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 12, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 6, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 8, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 4, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 3, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 21, 2024RFNTREFUSAL PROCESSED BY IB—
Dec 5, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 5, 2024RFRRREFUSAL PROCESSED BY MPU—
Nov 19, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 18, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 7, 2024DOCKASSIGNED TO EXAMINER—
Jul 26, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 26, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance